Headquarters
Petah Tikva, IsraelFounded
2011CEO / Founder
Erez MeltzerEmployees
201-500Funding
PublicStock
NNOXProducts
0 products listedWebsite
www.nanox.vision/Profile updated
Nano-X Imaging is a medical imaging and AI company founded in 2011 in Israel by Ran Poliakine. The company develops the Nanox.ARC, a multi-source, cold-cathode digital tomosynthesis system, and offers FDA-cleared AI solutions and teleradiology services aimed at broadening access to preventive imaging.
Nanox went public on NASDAQ in August 2020 (NNOX). Ran Poliakine passed away in 2024; Erez Meltzer serves as Acting Chairman and CEO.
No products listed yet for this company.
Key milestones in Nanox's history, with sources.
FDA clears Nanox.ARC for expanded general use
The FDA expanded Nanox.ARC's clearance beyond musculoskeletal imaging to general use including pulmonary, intra-abdominal, and paranasal sinus indications.
diagnosticimaging.comFounder Ran Poliakine dies
Nanox founder and non-executive chairman Ran Poliakine, who took the company public in 2020 and had moved to a non-executive role in 2021, died of a medical condition.
itnonline.comFDA clears multi-source Nanox.ARC for musculoskeletal imaging
The FDA granted 510(k) clearance for the multi-source Nanox.ARC (with Nanox.CLOUD), a digital tomosynthesis system, for musculoskeletal imaging in professional healthcare settings.
itnonline.comCompletes Zebra Medical Vision merger, rebrands it Nanox.AI; also closes USARAD and MDWEB deals
Per its SEC filing, Nanox closed the Zebra Medical Vision merger on Nov 4, 2021 (3,249,142 shares plus deferred/contingent consideration up to $87.3M total), renaming the unit Nanox AI Ltd; it separately closed the USARAD Holdings teleradiology acquisition ($7.3M cash + stock, Nov 2) and the MDWEB marketplace acquisition (stock, Nov 3) the same week.
sec.govAgrees to acquire Zebra Medical Vision for up to $200M
Nanox signed a merger agreement to acquire Israeli deep-learning medical-imaging analytics company Zebra Medical Vision in an all-stock deal: $100M upfront plus up to $100M in milestone-based consideration.
hitconsultant.netFirst FDA 510(k) clearance for Nanox.ARC (single-source)
The FDA cleared the single-source version of the Nanox.ARC digital X-ray system for marketing, the company's first regulatory clearance for its core imaging hardware.
itnonline.comIPO on Nasdaq under ticker NNOX
Nano-X Imaging priced its upsized IPO at $18/share and began trading on Nasdaq as NNOX, closing up 20.6% at $21.70 on debut day; gross proceeds were reported near $190M, valuing the company at roughly $1B.
techcrunch.comBrowse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.